Broadfin Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$33.3M Sell
350,000
-350,000
-50% -$30.3M 4.46% 3
2019
Q3
$53.4M Buy
+700,000
New +$58.2M 9.87% 2
2019
Q1
Sell
-700,000
Closed -$50.2M 48
2018
Q4
$50.2M Buy
700,000
+540,000
+338% +$43.5M 6.6% 3
2018
Q3
$15.3M Buy
+160,000
New +$15.5M 2.26% 15
2017
Q3
Sell
-1,000,000
Closed -$77.2M 53
2017
Q2
$77.2M Hold
1,000,000
9.38% 1
2017
Q1
$69.3M Buy
+1,000,000
New +$67.2M 8.4% 3
2016
Q4
Sell
-500,000
Closed -$33.1M 69
2016
Q3
$33.1M Buy
+500,000
New +$30.9M 2.97% 9
2016
Q1
Sell
-1,000,000
Closed -$70.2M 86
2015
Q4
$70.2M Hold
1,000,000
4.32% 5
2015
Q3
$62.3M Buy
1,000,000
+145,000
+17% +$11.4M 3.46% 5
2015
Q2
$71.9M Buy
+855,000
New +$66.5M 3.86% 5

Other funds holding XBI